Novel Coronavirus RNA-Protein Targets

High-resolution microscopic visualization of a coronavirus particle highlighting intricate RNA and protein structures.
Image Credit: Scientific Frontline / AI generated

Scientific Frontline: Extended "At a Glance" Summary: Coronavirus RNA-Protein Interactions

The Core Concept: Researchers have mapped the intricate interactions between viral RNA and the proteins responsible for coronavirus replication and regulation. By identifying these highly conserved RNA binding sites, scientists have uncovered new fundamental molecular targets for variant-resistant antiviral treatments.

Key Distinction/Mechanism: Unlike current treatments that target highly mutable viral features, this approach uses enhanced cross-linking and immunoprecipitation (eCLIP) to map the entire viral genome. It targets essential, underlying molecular machinery that is conserved across coronavirus species, making it exceedingly difficult for the virus to evade the therapy through mutation.

Major Frameworks/Components:

• Enhanced cross-linking and immunoprecipitation (eCLIP): A genome-scale mapping technique used to survey and identify unexpected RNA-protein interaction sites across the entire viral genome.
• Target proteins: The research identified critical RNA binding sites for primase cofactor (NSP8), RNA-dependent RNA polymerase (NSP12), and the nucleocapsid (N) protein.
• The 5′ untranslated region: A complex RNA structure at the beginning of the genome that interacts with the N protein to regulate translation.
• Locked nucleic acids (LNAs): Short, modified nucleic acid sequences deployed to bind specific RNA regions, successfully blocking protein interactions and significantly reducing viral replication in animal cells and human lung cells.

Picobirnaviruses Infect Gut Bacteria, Not Humans

WashU Medicine researchers have rewritten the story on a group of viruses once thought to directly infect human tissue and play a role in gastrointestinal disease. They found that the common virus actually infects gut bacteria, redefining how these viruses impact human health.
Image Credit: Sara Moser/WashU Medicine

Scientific Frontline: Extended "At a Glance" Summary: Picobirnaviruses

The Core Concept: Picobirnaviruses are a prevalent group of RNA viruses within the human gut microbiome that act as bacteriophages, specifically infecting bacterial cells rather than human tissue.

Key Distinction/Mechanism: Unlike most stomach viruses that directly attack human cells to cause illness, picobirnaviruses multiply inside gut bacteria under oxygen-free conditions, meaning their association with gastrointestinal diseases stems from their disruption of the bacterial ecosystem.

Origin/History: First discovered nearly 40 years ago in stool samples from patients with diarrhea, these viruses were widely presumed to be human pathogens until an October 2026 study in Nature Microbiology revealed their true bacterial host.

Major Frameworks/Components:

• Viral Replication Environment: The viruses actively multiply in oxygen-free laboratory models populated by human gut bacteria, ceasing replication when exposed to antibiotics.
• Bacterial Host Identification: Using advanced molecular imaging, scientists identified the virus inside Candidatus Anaerotignum faecalis, a newly classified gut bacterium.
• Viral Classification: The discovery reclassifies the Picobirnaviridae family, establishing them as only the third known clade of RNA bacteriophages.
• Disease Pathology: Although not directly infecting human cells, picobirnaviruses may contribute to clinical conditions like acute diarrhea, Type 1 diabetes, and graft-versus-host disease by destroying beneficial microbes and triggering inflammation.

SARS-CoV-2 RNA-Protein Drug Targets

The hidden RNA–protein landscape of SARS-CoV-2. A cutaway view of the virus reveals its RNA genome and associated viral proteins. We systematically mapped protein–RNA interactions across the SARS-CoV-2 genome to uncover previously unknown regulatory sites that contribute to viral replication. Large purple: RNA-dependent RNA polymerase (RdRp; NSP12); small yellow: NSP8 (polymerase cofactor/primase); blue: nucleocapsid (N) protein.
Image Credit: UCR/Xiang lab / AI generated

Scientific Frontline: Extended "At a Glance" Summary: SARS-CoV-2 RNA-Protein Interactions

The Core Concept: Researchers have comprehensively mapped previously unknown interactions between viral RNA and essential replication proteins across the SARS-CoV-2 genome to identify novel antiviral drug targets.

Key Distinction/Mechanism: Rather than targeting rapidly mutating features like the spike protein, this approach disrupts essential, highly conserved RNA-protein interactions—such as those involving RNA-dependent RNA polymerase (RdRp) and the nucleocapsid (N) protein—minimizing the virus's ability to develop drug resistance.

Major Frameworks/Components:

• Enhanced cross-linking and immunoprecipitation (eCLIP): An advanced genomic mapping technique used to survey the entire viral genome and identify unexpected protein-RNA interaction sites.
• Nucleocapsid (N) protein regulation: The N protein was found to interact with the highly conserved 5′ untranslated region of the viral genome, appearing to regulate the translation of viral RNA into proteins.
• RNA-dependent RNA polymerase (RdRp): Beyond its known role in copying the genome, RdRp interacts with the RNA encoding viral protein NSP3, suggesting RNA plays complex regulatory roles.
• Antisense oligonucleotides: Short, modified nucleic acid sequences used experimentally to block these critical interaction sites, successfully reducing viral replication in laboratory settings.

2025 Marburg Outbreak: Genomic Tracking in Ethiopia

Marburg virus, captured with the specific appearance of a colorized Transmission Electron Micrograph (TEM)
Image Credit: Scientific Frontline / AI generated

Scientific Frontline: Extended "At a Glance" Summary: The 2025 Ethiopian Marburg Virus Outbreak

The Core Concept: The 2025 Marburg virus outbreak in Ethiopia, a highly fatal viral hemorrhagic fever, was traced to a single zoonotic spillover event from animals to humans through rapid genomic analysis.

Key Distinction/Mechanism: Unlike outbreaks characterized by multiple independent animal-to-human transmission events, genetic sequencing of the virus revealed remarkably little variation between patient samples, proving the outbreak descended from a shared ancestral virus via a single chain of transmission.

Origin/History: The outbreak emerged in Ethiopia in November 2025, infecting 14 individuals and yielding a 64 percent case fatality rate, with the suspected patient zero having worked at a construction site colonized by Egyptian fruit bats (Rousettus aegyptiacus).

Major Frameworks/Components:

• Genomic-based surveillance to identify and map the viral genome.
• Rapid diagnostic sequencing workflows used to confirm the causative agent within 48 hours.
• Epidemiological contact tracing to track the localized, human-to-human transmission chain.
• Zoonotic pathogen transmission modeling from a known animal reservoir to human populations.

Ancient Virus Silences Chimp Brain Gene

Researchers have discovered that an ancient viral remnant in the chimpanzee genome silences the LINC00662 gene.
Photo Credit: Fabiana Rizzi

Scientific Frontline: Extended "At a Glance" Summary: Viral Silencing of LINC00662 in Chimpanzees

The Core Concept: An ancient endogenous retrovirus (PTERV1) integrated into the chimpanzee genome millions of years ago, epigenetically silencing the LINC00662 gene through DNA methylation, whereas this same gene remains highly active during early human brain development.

Key Distinction/Mechanism: While humans and chimpanzees share nearly identical genetic repertoires, their gene regulation differs significantly. In chimpanzees, the PTERV1 viral insertion dictates the methylation and deactivation of LINC00662. Removing this viral sequence via CRISPR-Cas9 in chimpanzee brain organoids restores the gene's expression, whereas deliberately silencing it in human organoids impairs nerve cell development and synaptic connectivity.

Origin/History: The PTERV1 endogenous retrovirus infected chimpanzee populations millions of years ago, becoming permanently embedded within their germline DNA and passing to subsequent generations—an infection the human lineage avoided.

Major Frameworks/Components:

• Endogenous retroviruses (PTERV1) and germline genetic integration.
• Epigenetic regulation through systemic DNA methylation.
• Three-dimensional brain organoids derived from induced pluripotent stem cells to model neurological development.
• CRISPR-Cas9 gene editing for targeted sequence excision and gene silencing.
• The LINC00662 gene and its role in neurogenesis and neural circuitry formation.

SARS-CoV-2 Infects Human Neural Stem Cells

Photo shows Ann Song (left), Cori Zuvia (center), and Prue Talbot.
Photo Credit: UCR/Talbot lab

Scientific Frontline: Extended "At a Glance" Summary: Human Neural Stem Cell Susceptibility to SARS-CoV-2

The Core Concept: Human neural stem cells, the foundational cells for the brain and spinal cord, demonstrate a high susceptibility to infection by SARS-CoV-2, including the original viral spike and the Omicron variants (BA.1 and BA.2).

Key Distinction/Mechanism: The study used modified, non-replicating virus particles (pseudoparticles) to safely observe infection. The research revealed that Omicron pseudoparticles infect neural stem cells primarily through endocytosis (cell engulfment), a pathway that could be blocked by the compound filipin. Furthermore, neural stem cells possess a sparse cell-surface sugar layer (glycocalyx); removing these sugar molecules increased viral entry twofold to fourfold, suggesting the layer normally limits viral access.

Origin/History: The research, led by Professor Prue Talbot at the University of California, Riverside, and published in PLOS One (October 2026), addresses the potential consequences of maternal COVID-19 infection on fetal neurodevelopment, aligning with large health-record studies linking maternal infection to increased risks of neurodevelopmental diagnoses in children by age three.

Major Frameworks/Components:

• Ectodermal Differentiation: Human embryonic stem cells differentiated into neural stem cells.
• Viral Entry Mechanisms: Utilization of spike pseudoparticles to model SARS-CoV-2 cellular invasion via endocytosis.
• Glycocalyx Interference: The role of cell-surface sugar groups in modulating viral access.

Boosting Host-Directed Viral Defenses

Lindsay Grace Miller, a Washington State University graduate student in Professor Santanu Bose's lab, initiated the project that identified a cellular signaling pathway researchers used to boost antiviral defenses.
Photo Credit: Washington State University

Scientific Frontline: Extended "At a Glance" Summary: Extracellular ISG15 Antiviral Pathway

The Core Concept: The extracellular ISG15 antiviral pathway is a naturally occurring cellular signaling mechanism that boosts a host cell's innate defenses to resist infection before a virus can spread.

Key Distinction/Mechanism: Unlike traditional antiviral drugs that directly target viral proteins, this host-directed approach strengthens the cell's own protective machinery via the extracellular ISG15 protein, rendering it less vulnerable to viral mutations.

Major Frameworks/Components:

• ISG15 Protein: A cellular factor naturally induced during infection that acts outside the cell as a "booster" to activate defense pathways.
• Recombinant ISG15: A synthetic protein used to artificially amplify the pathway's activation, resulting in robust cellular resistance to pathogens.
• Host-Directed Therapeutics: A treatment strategy focusing on enhancing host cellular responses rather than targeting the virus directly.
• Broad-Spectrum Efficacy: Demonstrated protective effects against respiratory syncytial virus (RSV), influenza A, and parainfluenza viruses.

NeuroHIV Target Identified: MAPK14 Brain Protein

Image shows an activated microglial cell next to other cells in a mouse brain.
Image Credit: UCR/Kaul lab AI generated / Gemini

Scientific Frontline: Extended "At a Glance" Summary: MAPK14 and NeuroHIV

The Core Concept: A specific brain protein, MAPK14 (or p38α mitogen-activated protein kinase), has been identified as a critical driver of the inflammatory response that causes brain damage and cognitive impairment in long-term HIV infections, a condition known as neuroHIV.

Key Distinction/Mechanism: Unlike the viral infection itself, the damage is caused when MAPK14 is activated in microglial cells (the brain's resident immune cells) simply by exposure to a component of the HIV envelope (gp120), inducing a neurotoxic state that harms dendrites and synapses.

Major Frameworks/Components:

• Microglia: The brain's resident immune cells, which carry binding sites for the HIV envelope protein.
• MAPK14 (p38α): A gene and protein integral to inflammatory responses.
• HIV Envelope Protein gp120: The viral component that interacts with microglia to trigger the neurotoxic cascade.
• NeuroHIV Mouse Model (HIVgp120tg): A transgenic model expressing the HIV envelope protein, used to demonstrate that removing MAPK14 from microglia prevents brain injury.

Mpox PCR Tests Show High Rate of False Positives

Mpox Virus Colorized transmission electron micrograph of immature mpox virus particles (red with tan viral envelope) found within an infected VERO E6 cell (teal), cultured in the laboratory.
Image Credit: National Institute of Allergy and Infectious Diseases

Scientific Frontline: Extended "At a Glance" Summary: False-Positive Mpox Diagnoses

The Core Concept: A significant portion of positive mpox PCR tests may indicate environmental contamination rather than active viral infection.

Key Distinction/Mechanism: Researchers identified that true active infections cluster at low CT values (high viral load), while false positives cluster exactly at the detection threshold, indicating residual viral traces likely picked up from contaminated surfaces in treatment centers.

Origin/History: The study analyzed PCR results from four Congolese cities between April 2024 and April 2026, following the WHO's August 2024 declaration of the mpox upsurge in the Democratic Republic of the Congo as a Public Health Emergency of International Concern.

Major Frameworks/Components:

• PCR testing relies on CT values to determine viral load.
• Mpox viral DNA is highly stable and can persist for weeks on surfaces or in the air, creating a high risk of cross-contamination during patient sampling.
• Serological data supported the findings, with 89% of suspected false positives showing no trace of antibodies against the virus.
• Lowering the PCR positivity threshold was identified as a viable method to reduce false positives without significantly increasing false negatives.

Delphy Software Rapidly Tracks Viral Variants & Outbreaks

Image Credit: Susanna Hamilton

Scientific Frontline: Extended "At a Glance" Summary: Delphy Software for Viral Variant Tracking

The Core Concept: Delphy is a web-based software application designed to rapidly assemble phylogenetic trees, mapping the evolution and spread of viral variants from genomic sequence data in near-real time.

Key Distinction/Mechanism: Delphy operates entirely within a web browser, processing data locally on the user's device without requiring specialized infrastructure or an internet connection after loading. It achieves analysis speeds 100 to 1,000 times faster than existing methods by streamlining and optimizing the underlying statistical models, completing tasks that previously took months in hours.

Origin/History: The software was conceptualized mid-2020 by Patrick Varilly, Pardis Sabeti, and Ben Fry to address the computational bottleneck of analyzing vast quantities of SARS-CoV-2 genomic data during the COVID-19 pandemic.

Major Frameworks/Components:

• Bayesian phylogenetics
• Interactive data visualization algorithms
• Web browser-based local execution environments

Zika Vaccine Design: Balancing Antibodies and T Cells

Aedes mosquito.
This species can transmit pathogens such as Zika, Chikungunya, and dengue virus.
Photo Credit: NIAID

Scientific Frontline: Extended "At a Glance" Summary: Zika Virus Vaccine Development

The Core Concept: Researchers evaluated two experimental Zika virus vaccines to understand the roles of antibodies and T cells, discovering that long-term viral protection requires a coordinated immune response from both components rather than relying on T cells alone.

Key Distinction/Mechanism: Traditional vaccines generate neutralizing antibodies, which carry the risk of triggering antibody-dependent enhancement (ADE) upon exposure to closely related orthoflaviviruses, such as dengue. To circumvent this, a modified vaccine mutated the viral fusion loop to avoid ADE; however, this vaccine relied entirely on CD8\(^+\) T cells and lost its efficacy after 12 weeks, demonstrating that durable immunity requires both targeted antibodies and T cells.

Origin/History: The Zika virus caused a major global public health emergency in 2016 following an outbreak across the Americas that led to severe birth defects. This recent study, published in Nature Microbiology, addresses the ongoing lack of licensed Zika treatments.

Major Frameworks/Components:

• CD8+ T Cells: Specialized immune cells that actively locate, target, and destroy virus-infected cells.
• Neutralizing Antibodies: Immune proteins that bind to a pathogen's outer surface, disabling the virus before it can cause an infection.
• Antibody-Dependent Enhancement (ADE): A phenomenon where sub-optimal or cross-reactive antibodies inadvertently help a closely related virus enter host immune cells, resulting in a significantly more severe infection.
• Orthoflaviviruses: A family of mosquito-borne viruses that includes Zika, dengue, and Japanese encephalitis, primarily transmitted by Aedes mosquitoes.
• Fusion Loop: A specific patch on the virus's outer envelope protein that generates the cross-reactive antibodies largely responsible for ADE.

What Is: Paleovirology and Permafrost Pathogens

Scientific Frontline: Extended "At a Glance" Summary: Paleovirology and Permafrost Pathogens

The Core Concept: Paleovirology within the context of the cryosphere involves the physical extraction, isolation, and resurrection of viable, ancient microorganisms—often referred to as "zombie viruses"—that have been preserved in a state of cryptobiosis within thawing permafrost for tens of thousands to over a million years.

Key Distinction/Mechanism: Unlike standard decay in temperate zones, the strictly anoxic, pH-neutral, and sub-zero environment of Yedoma permafrost, combined with the physical shielding provided by clay minerals, suspends the biological clock of extracellular viruses and bacteria, preventing enzymatic, oxidative, and metabolic degradation indefinitely.

Origin/History: The modern physical resurrection of ancient permafrost viruses was catalyzed by the 2003 characterization of giant viruses like Acanthamoeba polyphaga mimivirus, which led to the successful revival of Pithovirus sibericum in 2014, Mollivirus sibericum in 2015, and thirteen distinct prehistoric viruses in a landmark 2023 study.

Paleovirology: In-Depth Description

Paleovirology is the study of ancient viruses and their evolutionary history, primarily conducted by examining endogenous viral elements (EVEs) that have integrated into the genomes of host organisms over millions of years. Its primary goal is to reconstruct the molecular "fossil record" of viruses to understand their ancient origins, long-term mutation rates, and the profound ways they have shaped the evolutionary trajectories of modern species.

New Antibody Therapy Target for Tick-Borne CCHFV Discovered

Scott D. Pegan, Ph.D. Professor, Biomedical Sciences Associate Dean of Pre-Clerkship Medical Education
Photo Credit: Courtesy of University of California, Riverside

Scientific Frontline: Extended "At a Glance" Summary: CCHFV Antibody Therapy

The Core Concept: Researchers have discovered that the internal nucleocapsid protein (NP) of the Crimean-Congo hemorrhagic fever virus (CCHFV) can serve as a viable target for protective antibodies, offering a new pathway for therapeutics against the disease.

Key Distinction/Mechanism: Unlike neutralizing antibodies that target surface proteins to prevent viral entry, these non-neutralizing antibodies target the NP. It is hypothesized they bind to the NP on the surface of infected cells or free-floating NPs, which are then taken inside the cell to interact with the intercellular protein TRIM21, mobilizing the immune system to clear the infection.

Major Frameworks/Components:

• Nucleocapsid Protein (NP): An internal viral protein previously used primarily for diagnostics, now identified as a therapeutic target with four distinct binding areas for antibodies (on its "head" and "stalk").
• Antibody 9D5: A powerful, non-neutralizing mouse antibody that binds to the head region of the NP, protecting against lethal infection and demonstrating broad-spectrum potential.
• TRIM21 Pathway: An intercellular protein mechanism that appears to facilitate the immune system's response when NP-targeting antibodies are internalized.

Triple-Dose Regimen May Clear HIV in Newborns

Jonah Sacha, Ph.D. 
Photo Credit: OHSU/Christine Torres Hicks

Scientific Frontline: Extended "At a Glance" Summary: Triple-Dose HIV Regimen for Newborns

The Core Concept: A one-time, three-part therapeutic regimen administered within 72 hours of birth that demonstrates the potential to permanently clear HIV infection in exposed newborns.

Key Distinction/Mechanism: Unlike standard treatments that only suppress the virus, this approach combines three distinct mechanisms to achieve clearance: antiretroviral therapy minimizes active viral replication, neutralizing antibodies corral circulating virus in the bloodstream, and the monoclonal antibody leronlimab blocks residual HIV from entering immune cells by sealing off the CCR5 surface receptor.

Major Frameworks/Components:

• Antiretroviral Therapy (ART): Standard treatment utilized to halt and minimize active viral replication.
• Broadly Neutralizing Antibodies: Immune proteins deployed to capture and reduce the volume of virus circulating within the blood supply.
• CCR5 Blockade: Application of leronlimab, an experimental monoclonal antibody, to inhibit HIV from accessing the CCR5 surface protein on immune cells.
• Critical Window of Efficacy: Treatment requires administration within a strict three-day (72-hour) window following initial viral exposure.

SARS-CoV-2 Nucleocapsid Protein and Long COVID

Dr. Melody Li with members of her lab.
Photo Credit: Timothy Archibald/UCLA Broad Stem Cell Research Center

Scientific Frontline: Extended "At a Glance" Summary: SARS-CoV-2 Nucleocapsid Protein

The Core Concept: The SARS-CoV-2 nucleocapsid protein is a viral structural component that packages the virus's genetic material and unexpectedly amplifies inflammatory signals in immune cells, contributing to profound tissue damage.

Key Distinction/Mechanism: While coronaviruses typically encode proteins to suppress early immune responses, the nucleocapsid protein acts as a "double-edged sword." It successfully dampens early antiviral defenses while simultaneously overactivating inflammatory pathways in macrophages, causing them to release tissue-damaging cytokines and chemokines.

Origin/History: Detailed in a recent study published in Science Advances by a UCLA research team led by virologist Melody Li, the research compared nucleocapsid proteins from SARS-CoV-1, MERS-CoV, and various SARS-CoV-2 variants, noting the Delta variant as the most inflammatory.

Major Frameworks/Components:

• Macrophages: Immune cells that detect viruses and coordinate early responses, which become hyperactivated by the nucleocapsid protein.
• Endothelial cells: The cells lining blood vessels that form vital protective barriers, such as the blood-brain barrier and the coronary artery lining.
• Vascular leakage: The breakdown of endothelial barriers caused by severe inflammatory signals, which was prominently observed in stem cell-derived heart models exposed to the Delta variant.
• Cytokines and chemokines: Chemical signals released by patrolling macrophages that drive the systemic hyperinflammatory response.

MDV: How Avian Viruses Evade Vaccines

A new genome-wide study of the virus that causes Marek’s disease in chickens has identified 10 regions in the virus genome that are associated with an increase in virulence — how severe the disease is and whether it can break through vaccine protection. The study could inform the development of next-generation vaccines that are more effective at preventing future breakthroughs.
Photo Credit: Heidi-Ann Fourkiller

Scientific Frontline: Extended "At a Glance" Summary: Marek's Disease Virus Evolution

The Core Concept: A highly contagious avian herpesvirus that causes Marek's disease, which manifests as tumors and paralysis in poultry, and has progressively evolved to evade multiple generations of vaccines.

Key Distinction/Mechanism: Unlike typical viral models where vaccines provide sterilizing immunity, Marek's disease vaccines delay symptoms rather than preventing transmission, which allows the virus to continuously circulate and mutate. A genome-wide association study (GWAS) identified ten specific genomic variants—most notably a tandem repeat DNA sequence—that statistically correlate with the virus's ability to break through vaccine-induced protection and achieve high virulence.

Origin/History: The virus has caused significant agricultural losses for decades, with widespread commercial vaccination protocols beginning in the 1970s. For this study, researchers sequenced the entire genomes of 65 viral strains, which were originally collected by the United States Department of Agriculture between 1962 and 2016.

Major Frameworks/Components:

• Pathotyping: The classification of viral strains into four specific disease categories, or "pathotypes," based on symptom severity and the pathogen's capacity to bypass vaccine defenses.
• Genome-Wide Association Study (GWAS): A computational analysis utilized to identify statistical correlations between specific DNA variants, such as single-nucleotide polymorphisms, insertions, or deletions, and observable disease severity.
• Phylogenetic Mapping: The construction of a viral evolutionary tree revealing that the most highly virulent strains share a common ancestor, which helps isolate the search for key mutational variants.
• Tandem Repeats: A specific structural DNA mutation where a genetic segment is duplicated, identified as the strongest genomic correlate with hypervirulence.

What Is: Bacteriophages

Scientific Frontline: Extended "At a Glance" Summary: Bacteriophages: Viral Predators and Phage Therapy

The Core Concept: Bacteriophages are the most abundant and diverse viral entities on Earth, functioning as microscopic apex predators that exist exclusively to infect, replicate within, and ultimately lyse bacterial populations.

Key Distinction/Mechanism: Operating at the precise boundary of chemistry and life, these viruses utilize extreme thermodynamic pressurization for passive DNA injection, complex bistable genetic switches to govern lytic versus lysogenic life cycles, and profound molecular mimicry to hijack bacterial host metabolism.

Origin/History: The antibacterial properties of bacteriophages were first empirically observed by Ernest Hankin in 1896, with formal discovery credited independently to Frederick Twort in 1915 and Felix d'Herelle, who officially coined the term "bacteriophage" in 1917.

Major Frameworks/Components:

• The "Viral Shunt": A macroscopic biogeochemical process where phage-induced bacterial lysis prevents sequestered nutrients from moving up the classical grazing food web, instead redirecting carbon and essential elements back into the microbial loop to regulate planetary ecosystems.
• The 2022 ICTV Taxonomic Revolution: A radical, genome-based restructuring of viral classification that permanently abolished morphology-based orders, reorganizing tailed viruses into the class Caudoviricetes utilizing freeform binomial nomenclature.
• The Lambda Phage Genetic Switch: An elegant thermodynamic regulatory network driven by the competitive binding of CI repressor dimers and Cro proteins, determining whether the virus enters a dormant lysogenic state or initiates a destructive lytic cycle.
• The Z-DNA Alphabet: An extreme evolutionary deviation where specific phages evade bacterial restriction endonucleases by substituting canonical adenine with 2,6-diaminopurine, synthesized via specialized viral-encoded enzymes like PurZ and polymerized by DpoZ.
• Anti-CRISPR (Acr) Proteins: Highly specific, convergently evolved viral proteins, such as AcrIIA26, that deploy steric occlusion and molecular mimicry to neutralize bacterial CRISPR-Cas adaptive immune systems.

NMT1 Antiviral Pathway Breakthrough

Dr Merja Joensuu (R) and a colleague, look at cells through a microscope.
Photo Credit: The University of Queensland

Scientific Frontline: Extended "At a Glance" Summary: NMT1 Antiviral Pathway Breakthrough

The Core Concept: A novel antiviral treatment strategy that inhibits the human enzyme N-myristoyltransferase 1 (NMT1) to prevent viruses from successfully assembling and replicating inside host cells.

Key Distinction/Mechanism: Traditional antivirals target the pathogen directly, which frequently leads to viral mutation and drug resistance. This new approach instead disrupts the human cellular pathway that viruses hijack during reproduction. By altering host cell function, the targeted pathway forces the cell to produce defective, less-effective viral particles, granting the immune system critical time to clear the infection.

Major Frameworks/Components:

• Enzymatic Target: The therapy utilizes a compound—currently undergoing clinical trials as a cancer treatment—to inhibit NMT1, an enzyme responsible for directing protein location and function within cells.
• Viral Assembly Disruption: By altering spatial organization and cellular function, the drug ensures that new viral copies are constructed incorrectly.
• Broad-Spectrum Efficacy: Laboratory cell culture tests demonstrated significant efficacy against diverse infectious agents, including SARS-CoV-2, respiratory syncytial virus (RSV), and vesicular stomatitis virus.
• Rapid Pathogen Reduction: Researchers observed viral infection levels drop by approximately 50 percent after one day, and up to 90 percent after two days.

Bourbon Virus in Lone Star Ticks

The lone star tick, shown on this plant leaf, can transmit the Bourbon virus.
Photo Credit: Ilia Rochlin, Stony Brook University.

Scientific Frontline: Extended "At a Glance" Summary: Bourbon Virus and the Lone Star Tick

The Core Concept: The Bourbon virus is an emerging, rare viral pathogen transmitted by the lone star tick (Amblyomma americanum) that causes severe, influenza-like illness in humans.

Key Distinction/Mechanism: Unlike common bacterial tick-borne illnesses, such as Lyme disease or ehrlichiosis, the Bourbon virus is viral and does not respond to standard antibiotic treatments like doxycycline. Furthermore, the absence of commercial testing makes acute diagnosis highly difficult, requiring specialized antibody titer analysis.

Major Frameworks/Components:

• Transmission Vector: The lone star tick, which also acts as a vector for ehrlichiosis, tularemia, and alpha-gal syndrome.
• Symptom Profile: Initial symptoms closely mimic other tick-borne infections, presenting as fever, fatigue, rash, severe headaches, body aches, and nausea.
• Laboratory Diagnostics: Due to the lack of exact commercial tests, disease confirmation requires sending blood samples to state health departments to detect neutralizing antibodies; a four-fold or greater rise in antibody titers indicates an acute or recent infection.
• Epidemiological Risk: Research examining 107 individuals with tick-borne illness symptoms revealed two cases with Bourbon virus antibodies, suggesting the pathogen is likely more prevalent in regions with dense tick populations than previously diagnosed.